| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 |
| filingDate |
2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05edcf9bf23124df4d6a12702c29cf35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc7b46df6dc97ff4c5e9816fe264cc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc8c265f081946dc31305c488d9f8bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_720a64ed3a5a788418b28f36c2d7b069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b3fe4180f1ce4e4fb99c4ed3da12d94 |
| publicationDate |
2014-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201443016-A |
| titleOfInvention |
Hydroxamic acid derivative having indoleamine-indoleamine as an effective histone deacetylase inhibitor and its medical use |
| abstract |
The present invention relates to a novel guanamine compound of the general formula (I) and as an antitumor and pro-apoptotic factor. The present invention encompasses the medical use of the above compounds in cancer diseases and other diseases associated with histone deacetylase inhibition, and pharmaceutical compositions containing the above compounds. □ |
| priorityDate |
2013-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |